Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
870.62B
Market cap870.62B
Price-Earnings ratio
40.08
Price-Earnings ratio40.08
Dividend yield
0.68%
Dividend yield0.68%
Average volume
2.70M
Average volume2.70M
High today
$921.98
High today$921.98
Low today
$902.23
Low today$902.23
Open price
$909.39
Open price$909.39
Volume
2.62M
Volume2.62M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 870.62B, Eli Lilly(LLY) trades at $919.00. The stock has a price-to-earnings ratio of 40.08 and currently yields dividends of 67.7%.

During the trading session on 2026-04-22, Eli Lilly(LLY) shares reached a daily high of $921.98 and a low of $902.23. At a current price of $919.00, the stock is +1.9% higher than the low and still -0.3% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 2.62M, versus its average volume of 2.7M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

The Motley Fool 3h
Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation.

At first glance, Eli Lilly's (LLY +1.97%) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assu...

Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation.
TipRanks 4h
Bernstein Pounds the Table on Eli Lilly Stock Ahead of Q1 Earnings

Wall Street brokerage Bernstein is pounding the table on Eli Lilly (LLY) stock ahead of the pharmaceutical company’s first-quarter financial results on April 30...

TipRanks 11h
Eli Lilly price target raised to $1,183 from $1,163 at Guggenheim

Guggenheim raised the firm’s price target on Eli Lilly (LLY) to $1,183 from $1,163 and keeps a Buy rating on the shares. The firm is updating its model ahead of...

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

TipRanks 13h
Rigel: Core Growth Thesis Intact Despite Eli Lilly’s R552 Exit, With Commercial Portfolio and R289 Pipeline Driving Buy Rating

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Rigel, with a price target of $57.00. Claim 30% Off TipRanks Unlock...

The Wall Street Journal 1d
Medicare Delays Full Obesity-Drug Program Rollout After Insurers Push Back

An Eli Lilly Zepbound injection pen. Shelby Knowles / Bloomberg News The Medicare agency will extend a short-term program that will pay for weight-loss drugs s...

Medicare Delays Full Obesity-Drug Program Rollout After Insurers Push Back
TipRanks 1d
Rigel Regains Rights as Eli Lilly Ends Collaboration

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 1d
UBS Pounds the Table on Eli Lilly Stock After Kelonia Therapeutics Deal

Analysts at Swiss bank UBS Group (UBS) are urging investors to buy Eli Lilly (LLY) stock after the pharma giant announced it is paying $7 billion to acquire can...

TipRanks 1d
Lilly, Novo slip after CVS opts out of Medicare obesity drug model

Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) are under pressure on Tuesday after CVS Health (CVS) announced the company’s decision regarding Medicare obesit...

Investor's Business Daily 1d
Amazon Stock: Anthropic And OpenAI Deals Highlight 'Growing Confidence' In Custom AI Chips

Eli Lilly and Novo Nordisk's Newest Rival In Weight Loss? Amazon. 3:58 AM ET Shares of Eli Lilly, Novo Nordisk and Viking Therapeutics tumbled Tuesday after Am...

Amazon Stock: Anthropic And OpenAI Deals Highlight 'Growing Confidence' In Custom AI Chips
Nasdaq 1d
Why Did Eli Lilly Stock Drop Today?

Key Points Eli Lilly is spending some of its GLP-1 money to buy up CAR-T gene therapy researchers. UBS analyst Michael Yee thinks that's smart strategy. 10 s...

Why Did Eli Lilly Stock Drop Today?

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.